Found 11 matching trials
A Study of SI-B001, an EGFR/HER3 Bispecific Antibody, in Locally Advanced or Metastatic Epithelial Tumors PHASE1 In phase Ia study, the safety and tolerability of SI-B001 in patients with ...
Show More Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
A Study of SI-B001+SI-B003± Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer PHASE1 Phase Ib: To observe the safety and tolerability of the combination of SI-B...
Show More Status
Active Not Recruiting
Location
Shanghai Pulmonary Hospital
Learn More & Join Trial
SI-B001 Combined With Chemotherapy in the Treatment of EGFR/ALK WT Recurrent or Metastatic NSCLC. PHASE2 This multi-center, open label phase II clinical study is performed in patie...
Show More Status
Active Not Recruiting
Location
Chongqing University Cancer Hospital
Learn More & Join Trial
A Clinical Study of SI-B001 in Combination With Paclitaxel/Docetaxel in the Treatment of Recurrent and Metastatic HNSCC PHASE2 This Phase IIa study is a clinical trial to evaluate the safety and efficac...
Show More Status
Active Not Recruiting
Location
The Second Affiliated Hospital of Guilin Medical University
Learn More & Join Trial
A Study of SI-B001+SI-B003± Chemotherapy in Patients With Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma PHASE1 Phase Ib: To observe the safety and tolerability of SI-B001+SI-B003 in comb...
Show More Status
Active Not Recruiting
Location
Shanghai Oriental Hospital
Learn More & Join Trial
A Clinical Study to Evaluate the Efficacy and Safety of SI-B001 in the Treatment of Recurrent and Metastatic HNSCC PHASE2 This multi-center, open label phase II clinical study is performed in patie...
Show More Status
Active Not Recruiting
Location
The Second Affiliated Hospital of Guilin Medical University
Learn More & Join Trial
SI-B001 as a Single Agent or in Combination With Chemotherapy in the Treatment of Digestive System Malignancies PHASE2 This multi-center, open label Phase II clinical study is performed in patie...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
SI-B001 Combined With Irinotecan in the Treatment of Recurrent Metastatic Esophageal Squamous Cell Carcinoma. PHASE2 This multi-center, open label Phase II clinical study is performed in patie...
Show More Status
Active Not Recruiting
Location
Beijing Cancer Hostital
Learn More & Join Trial
A Clinical Study of SI-B001 Combined With Docetaxel in the Treatment of Non-small Cell Lung Adenocarcinoma and Lung Squamous Cell Carcinoma PHASE3 Main objectives: To evaluate the benefit of SI-B001+ docetaxel on overall s...
Show More Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
A Study of SI-B001+SI-B003 Combined With Platinum-based Chemotherapy as First-line Treatment in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma PHASE2 This study is a open, multi-center phase II clinical study to explore the e...
Show More Status
Active Not Recruiting
Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial